24P Tepotinib in patients with MET exon 14 skipping NSCLC: Efficacy and safety by line of therapy
| Autor: | Griesinger, F., Felip, E., Smit, E.F., Veillon, R., Raskin, J., Thomas, M., Conte, P., Kowalski, D., Paz-Ares, L., Garcia Ledo, G., de Marinis, F., Scherz, A., Berghoff, K., Bruns, R., Otto, G., Paik, P. |
|---|---|
| Zdroj: | In Annals of Oncology April 2022 33 Supplement 2:S40-S41 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|